All Studies

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia

Sequencing of chimeric antigen receptor T-cell therapy and allogeneic transplantation in adult patients with B-cell acute lymphoblastic leukemia.

Measurable residual FLT3 internal tandem duplication before allogeneic transplant for acute myeloid leukemia.

DNA sequencing to detect residual disease in adults with acute myeloid leukemia prior to hematopoietic cell transplant

Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia.

Impact of donor source in second allogeneic hematopoietic cell transplant in patients with acute leukemia/MDS who relapsed after prior allograft during the current era (2014-2020).

Prognostic impact of cytogenetic and molecular risk classification in AML after hematopoietic stem cell transplant in adolescents and young adults.

The impact of allogeneic stem cell transplantation on acute myeloid leukemia and myelodysplastic syndrome with chromosome 3 abnormalities.

Impact of pre-allogeneic hematopoietic cell transplantation therapy in acute myeloid leukemia and myelodysplastic syndrome on post-transplant outcomes.

Impact of measurable residual disease status on outcomes of acute myeloid leukemia and patients 18-65 years old in first complete remission undergoing allogeneic hematopoietic cell transplantation.